Varaico: Literature-Extracted Genetic Variants

Gene:NOTCH3
Variant:p.R207C
Back to variants list

NOTCH3

NM_000435.3:p.R207C

Associated Papers

Gene Panel Approach to Screen for Hereditary Cerebral Small Vessel Disease: A Proof-of-Concept Study.

Ferraro C et al.

Genes, 2026

The Spectrum of NOTCH3 Variants in an Australian CADASIL Cohort.

Guyler SK et al.

Genes, 2025

41300806 (PubMed )
Supplement: genes-16-01353-s001.zip › genes-3932398-supplementary.pdf

Small Vessel Disease Phenotype Associated With Monoallelic NOTCH3 Loss-of-Function Variants.

van Asbeck JS et al.

Neurology, 2025

Association Between Vascular NOTCH3 Aggregation and Disease Severity in a CADASIL Cohort - Implications for NOTCH3 Variant-Specific Disease Prediction.

Cerfontaine MN et al.

Annals of Neurology, 2025

Clinical and Genetic Spectrum of Patients with Pediatric-Onset Epilepsy: Insights from a Single-Center Study.

Tozkir H et al.

Genes, 2025

A Search for New Biological Pathways in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy by Proteomic Research.

Menéndez-Valladares P et al.

Journal of Clinical Medicine, 2024

SNP and Structural Study of the Notch Superfamily Provides Insights and Novel Pharmacological Targets against the CADASIL Syndrome and Neurodegenerative Diseases.

Papageorgiou L et al.

Genes, 2024

The STROMICS genome study: deep whole-genome sequencing and analysis of 10K Chinese patients with ischemic stroke reveal complex genetic and phenotypic interplay.

Cheng S et al.

Cell Discovery, 2023

Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction.

Hack RJ et al.

Brain : a Journal of Neurology, 2023

Influence of different spectra of NOTCH3 variants on the clinical phenotype of CADASIL - experience from Slovakia.

Juhosová M et al.

Neurogenetics, 2023

Association of Vascular Risk Factors and Genetic Factors With Penetrance of Variants Causing Monogenic Stroke.

Cho BPH et al.

Jama Neurology, 2022

36300346 (PubMed )
Supplement: jamaneurol-e223832-s001.pdf

Genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients in different populations.

Ni W et al.

Cns Neuroscience & Therapeutics, 2022

Effect of NOTCH3 EGFr Group, Sex, and Cardiovascular Risk Factors on CADASIL Clinical and Neuroimaging Outcomes.

Hack RJ et al.

Stroke, 2022

35862191 (PubMed )
Supplement: str-53-3133-s001.pdf

NOTCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature.

Gravesteijn G et al.

Neuropathology and Applied Neurobiology, 2022

Genetic testing in dementia-A medical genetics perspective.

Huq AJ et al.

International Journal of Geriatric Psychiatry, 2021

NOTCH3 variants are more common than expected in the general population and associated with stroke and vascular dementia: an analysis of 200 000 participants.

Cho BPH et al.

Journal of Neurology, Neurosurgery, and Psychiatry, 2021

33712516 (PubMed )
Supplement: jnnp-2020-325838supp001.pdf

Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance.

Rutten JW et al.

Neurology, 2020

Clinical and Genetic Aspects of CADASIL.

Mizuno T et al.

Frontiers in Aging Neuroscience, 2020

32457593 (PubMed )
Supplement: Table_1.DOCX

GGC Repeat Expansion of NOTCH2NLC in Adult Patients with Leukoencephalopathy.

Okubo M et al.

Annals of Neurology, 2019

The role of clinical and neuroimaging features in the diagnosis of CADASIL.

Bersano A et al.

Journal of Neurology, 2018

Genotype-phenotype correlations of cysteine replacement in CADASIL.

Matsushima T et al.

Neurobiology of Aging, 2017

Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL.

Rutten JW et al.

Annals of Clinical and Translational Neurology, 2016

CADASIL in central Italy: a retrospective clinical and genetic study in 229 patients.

Bianchi S et al.

Journal of Neurology, 2015

Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke.

Kilarski LL et al.

Plos One, 2015

CADASIL and CARASIL.

Tikka S et al.

Brain Pathology (zurich, Switzerland), 2014

Interpretation of NOTCH3 mutations in the diagnosis of CADASIL.

Rutten JW et al.

Expert Review of Molecular Diagnostics, 2014

24844136 (PubMed )
Supplement: supplement_2.doc

Effects of cerebrolysin administration on oxidative stress-induced apoptosis in lymphocytes from CADASIL patients.

Formichi P et al.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013

Abnormal sensorimotor plasticity in CADASIL correlates with neuropsychological impairment.

Palomar FJ et al.

Journal of Neurology, Neurosurgery, and Psychiatry, 2013

Mutational and haplotype map of NOTCH3 in a cohort of Italian patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Testi S et al.

Journal of the Neurological Sciences, 2012

NOTCH3 mutations and clinical features in 33 mainland Chinese families with CADASIL.

Wang Z et al.

Journal of Neurology, Neurosurgery, and Psychiatry, 2011

Retinal nerve fiber layer thinning in CADASIL: an optical coherence tomography and MRI study.

Rufa A et al.

Cerebrovascular Diseases (basel, Switzerland), 2011

Apoptosis in CADASIL: an in vitro study of lymphocytes and fibroblasts from a cohort of Italian patients.

Formichi P et al.

Journal of Cellular Physiology, 2009

Structural and metabolic brain abnormalities in preclinical cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy.

Stromillo ML et al.

Journal of Neurology, Neurosurgery, and Psychiatry, 2009

Genetics of ischemic stroke: inheritance of a sporadic disorder.

Ross OA et al.

Current Neurology and Neuroscience Reports, 2009

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy and right-to-left shunt: lack of evidence for an association in a prevalence study.

Mazzucco S et al.

European Neurology, 2009

Increased QT variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Piccirillo G et al.

European Journal of Neurology, 2008

Plasma levels of asymmetric dimethylarginine in cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy.

Rufa A et al.

Cerebrovascular Diseases (basel, Switzerland), 2008

Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Rufa A et al.

Stroke, 2007

The spectrum of mutations for CADASIL diagnosis.

Federico A et al.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2005

The spectrum of Notch3 mutations in 28 Italian CADASIL families.

Dotti MT et al.

Journal of Neurology, Neurosurgery, and Psychiatry, 2005

Myocardial infarction in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Lesnik Oberstein SA et al.

Medicine, 2003

Diagnostic strategies in CADASIL.

Markus HS et al.

Neurology, 2002

Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis.

Joutel A et al.

Lancet (london, England), 2001

Cerebral microbleeds in CADASIL.

Lesnik Oberstein SA et al.

Neurology, 2001

Evaluation of DHPLC analysis in mutational scanning of Notch3, a gene with a high G-C content.

Escary JL et al.

Human Mutation, 2000

[CADASIL: genetics and physiopathology].

Joutel A et al.

Bulletin De L'academie Nationale De Medecine, 2000

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."